A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis

Clinical trial NCT03432533 · COMPLETED

Trial details

NCT number: NCT03432533
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Post-Menopausal Osteoporosis

Start date: 2018-02-06
Primary completion: 2019-04-11
Enrollment: 283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.